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Accepted 29 June 2012AbstractObjective: To test the hypothesis that human amniotic fluid mesenchymal stem cells contain a unique epigenetic signature in imprinting centers
of H19, SNRPN, and KCNQ1OT1 during in vitro cell culture.
Materials and Methods: By bisulfite genomic sequencing, we analyzed the imprinting centers of three imprinted genes (including H19, SNRPN,
and KCNQ1OT/) in a total of six single-cell clones of human amniotic fluid mesenchymal stem cells at cell passages 7, 8, 9, and 10 during
in vitro cell culture.
Results: The imprinting centers of H19 and KCNQ1OT1 showed hypermethylation at passage 7 in all single-cell clones of human amniotic fluid
mesenchymal stem cells, and there was no significant change in DNA methylation patterns during in vitro cell culture. The imprinting centers of
SNRPN showed variable methylation patterns at passage 7 in six single-cell clones, and DNA methylation patterns varied during in vitro cell
culture from passages 8 to 10.
Conclusion: In conclusion, human amniotic fluid mesenchymal stem cells contain a unique epigenetic signature during in vitro cell culture. H19
and KCNQ1OT1 possessed a substantial degree of hypermethylation status, and variable DNA methylation patterns of SNRPN was observed
during in vitro cell culture of human amniotic fluid mesenchymal stem cells. Our results urge further understanding of epigenetic status of human
amniotic fluid mesenchymal stem cells before it is applied in cell replacement therapy.
Copyright  2012, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Mesenchymal stem cells with the potential to differentiate
to adipocytes, chondrocytes, and osteocytes have been iso-
lated from human amniotic fluid [1e4]. Amniotic fluid
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http://dx.doi.org/10.1016/j.tjog.2012.07.004induced to differentiate into various tissue types, such as
skin, cartilage, cardiac tissue, nerve, muscle, bone, kidney,
and endothelium [4e8]. As AFMSCs are able to differentiate
into lineages representative of all three germ layers but do
not form tumors when injected in vivo [4,9] and are less
likely to raise ethical concerns of their generation, AFMSCs
have many potential applications in regenerative medicine
[4e6,8,10]. Tissue engineered products from mesenchymal
amniocytes had been used for diaphragm reconstruction in
lambs [11], trachea reconstruction in lambs [12], and sternum
repair in rabbits [13].cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
343H.-H. Peng et al. / Taiwanese Journal of Obstetrics & Gynecology 51 (2012) 342e349Recently, the potential applications of AFMSCs for cell-
based therapy had also been demonstrated in a sheep model
by using autologous stem cell transplantation in a sheep fetus
[14]. These autologous cells derived from AFMSCs showed
widespread organ migration in fetal tissues including liver,
heart, placenta, membrane, umbilical cord, adrenal gland, and
muscle. Although not proven in humans, the autologous
human AFMSCs may offer an alternative means to ameliorate
prenatal congenital disease [8] and could make it possible to
have an autologous cell source for adult diseases, such as heart
valve diseases [15]. However, considering the heterogeneity of
the cells found in amniotic fluid, we have further isolated and
characterized single-cell clones from amniotic fluid speci-
mens. The clonal amniotic fluid-derived stem cells can express
characteristics of both mesenchymal and neural stem cells [2].
A central assumption of Mendel’s laws of inheritance is that
genes originating frommaternal andpaternal genomesare equally
expressed in the offspring; however, there are some exceptions
[16]. In some disorders, such as BeckwitheWiedemann
syndrome (BWS), PradereWilli syndrome, and Angelman
syndrome (AS), the sex of the transmitting parent plays a role in
the expression of the phenotype in his or her affected children.
This led to the discovery of parental imprinted genes: a gene
expressed only from the paternally inherited chromosome is
maternally imprinted (the maternal allele is inactivated); simi-
larly, a gene expressed only from the maternally inherited chro-
mosome is paternally imprinted (the paternal allele is inactivated).
Progenies of assisted reproductive technologies are re-
ported to be at higher risk for an altered imprinting status,
leading to BWS [17,18] and AS [19,20]. In BWS, methylation
abnormalities are found in two differentially methylated
regions (DMR) that are located in 11q15: DMR1 of H19 and
DMR2 of KCNQ10T1 [20]. Defect of the SNRPN imprinting
control center/DMR in chromosome 15q11.2 is part of the
pathogenesis of AS.
Disturbed expression of particular imprinted genes has been
linked to fetal growth and development abnormalities as well
as other human diseases [21]. Previous studies on sheep [22]
and mouse embryos [23,24], and mouse stem cells [25] have
shown that they are prone to epigenetic variation and lose
normal imprinted gene expression when cultured in vitro. It
has been reported that the DNA methylation patterns of human
embryonic stem cells (hESCs) are distinct from those of other
cells [26]. Importantly, abnormal CpG island methylation
occurs during in vitro differentiation of hES. The more
passages embryonic stem cells experienced, the more they
appeared to differ from other cells of the same line that
underwent fewer passages [27].
Given the observations between assisted reproductive
technologies and human epigenetic disorders, we hypothe-
sized that human AFMSCs might have unique epigenetic
characters during in vitro cell culture. To fill the current
knowledge gap on AFMSCs, herein we study the epigenetic
characteristics of CpG islands of three imprinted genes (H19,
SNRPN, and KCNQ1OT1) on human AFMSC, especially
focusing on the differences among various single-cell clones
and the effect of in vitro cell culture on epigenetic changes ofimprinted genes on human AFMSCs. A better understanding
of the epigenetic characteristics of AFMSCs and their epige-
netic changes during in vitro cell culture will give us more
information for future applications of these AFMSCs in
disease therapy and tissue engineering.
Material and methodsPatient enrollmentWe recruited patients who were given prenatal care and
planning to deliver at the Department of Obstetrics and
Gynecology, Chang Gung Memorial Hospital (CGMH),
Taiwan. This study was approved by the Institute Review
Board of CGMH (IRB #97-1341A3). Patients were enrolled
only after written informed consents were obtained.Specimen collectionTwo amniotic fluid samples (AF20451744 andAF21251150)
were obtained after amniocentesis inCGMH [3].Amniocentesis
for medical reasons was performed between 16 and 20 weeks of
pregnancy, and a total of 20 mL of amniotic fluid was aspirated
from the amniotic sac transabdominally under sono-guide. The
fetal cells were cultured in Chang medium, and the adhering
cells were used for chromosomal studies. The nonadhering cells
suspended in Chang medium for the first 3 days were collected
for stem cells isolation and culture [1].Culture of single-cell clones of AFMSCsAFMSCs were cultured in alpha-modified minimum
essential medium (Hyclone, Logan, UT) supplemented with
20% fetal bovine serum (Hyclone) and 4 ng/mL basic fibro-
blast growth factor (R&D Systems, Minneapolis, MN) and
incubated at 37C in a humidified atmosphere with 5% CO2.
Isolation of single-cell clones of AFMSCs was performed
using cloning cylinders (Sigma, St. Louis, MO) on cell colo-
nies at the first 2 weeks of growth on plates. These single-cell
clones of AFMSCs were successively expanded and confirmed
to have mesenchymal stem cell surface antigen markers by
flow cytometry and differentiation abilities into osteoblasts,
chondrocytes, and adipocytes, as in our previous report [28].
In this study, AFMSCs were further characterized for the
pluripotent markers of Oct4 (R&D Systems) and Nanog (R&D
Systems) by flow cytometry.Chromosome study of two amniotic fluid samplesThe karyotypes of two amniotic fluid samples were
analyzed using a standard G-banding technique.Single-cell clones of AFMSC DNA extraction and
bisulfite treatment of DNAGenomic DNA from human AFMSC was extracted using
the QIAamp DNA Mini Kit (QIAGEN, Valencia, CA)
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and quantity of DNAwere analyzed by Nanodrop. Aliquots of
1 mg of DNA from AFMSCs underwent bisulfite conversion by
EpiTect Bisulfite Kit (Qiagen).Bisulfite PCR and sequencingThe eluted DNA samples (after bisulfite conversion) were
amplified using polymerase chain reaction (PCR) primers
specific for the DMRs of the imprinted genes being studied
(Fig. 1), including H19, SNRPN, and KCNQ1OT1, as previ-
ously described [16]. The primers used for bisulfite
sequencing are as follows:
H19_OuterF TTTTTGGTAGGTATAGAGTT
H19_OuterR AAACCATAACACTAAAACCC
H19_NestedF
TGTATAGTATATGGGTATTTTTGGAGGTTT
H19_NestedR
TCCTATAAATATCCTATTCCCAAATAACC
SNRPN_OuterF
GGTTTTTTTTTATTGTAATAGTGTTGTGGGG
SNRPN_OuterR
CTCCAAAACAAAAAACTTTAAAACCCAAATTC
SNRPN_NestedF
GGTTTTAGGGGTTTAGTAGTTTTTTTTTTTTTGG
SNRPN_NestedR
CAATACTCCAAATCCTAAAAACTTAAAATATC
KCNQ1OT1_F TGTTGAGGAGTTTYGGGGAGGATTA
KCNQ1OT1_R CACCTCACACCCAACCAATACCTCATFig. 1. Differentially methylated regions of H19, SNRPN, and KCNQ1OT1. DNA s
studied imprinted genes: H19, SNRPN, and KCNQ1OT1 are shown. H19 has 18 Cp
KCNQ1OT1 has 31 CpG sites in the DMR region. The CpG sites are labeled in rTOPO cloning of bisulfite PCR product and DNA
sequencingPCR products were cloned into the pCR2.1-TOPO vector
(Invitrogen, Carlsbad, CA) and transformed into competent
cells. Individual clones from at least two independent reac-
tions were selected for sequencing. The DNA sequence results
were then analyzed for the methylation status of the CpG
dinucleotide [16].Analysis of different passages of AFMSCWe studied and tracked cells in four different passages:
passages 7, 8, 9, and 10.
ResultsChromosome study of two amniotic fluid samplesThe karyotypes of both amniotic fluid samples were normal
female karyotypes (46,XX).Culture and characterization of single-cell clones of
AFMSCsSix single-cell clones of AFMSCs from two amniotic fluid
specimens were established. Three clones were from sample
AF20451744 and three clones were from sample
AF21251150. Besides the MSC surface markers that wereequences of differentially methylated regions (DMRs) and CpG islands of the
G sites in the DMR region, SNRPN has 23 CpG sites in the DMR region, and
ed.
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human AFMSCs were also strongly positive for Oct4 and
Nanog pluripotent markers (Fig. 2). The osteogenetic differ-
entiation capacity was identified by von Kossa staining of all
six single-cell clones of human AFMSCs (Fig. 3).
Epigenetic characteristics of CpG islands of imprinted gene
H19 on six single-cell clones derived from human AFMSCs
and the effect of in vitro cell culture on epigenetic changes of
imprinted gene H19 on human AFMSCs.
In the six single-cell clones of human AFMSCs, the DNA
methylation pattern shows a unique epigenetic signature of
hypermethylation in CpG islands of the imprinted gene H19.
In passage 7, the methylation rate was 79e98% in six single-
cell clones of amniotic fluid stem cells (Table 1). Further
studies on different passages (passages 8e10) showed no
significant methylation changes during in vitro cell culture. We
found that in passages 8e10 of six single-cell clones of
AFMSCs during in vitro cell culture, almost all wereFig. 2. Expression of Oct-4 and Nanog in single-cell clones of amniotic fluid mesen
cell (MSCs) (total, six clones) are harvested, and the stem cell surface markers ar
surface markers (both Oct-4 and Nanog) are strongly positive in all six clones ofhypermethylated with methylation rates of 65e96% with only
two exceptions (50% and 39%) (Table 1).
Epigenetic characteristics of CpG islands of imprinted gene
SNRPN on six single-cell clones derived from human
AFMSCs and the effect of in vitro cell culture on epigenetic
changes of imprinted gene SNRPN on human AFMSCs.
In the six single-cell clones of human AFMSCs, the DNA
methylation patterns showed variable methylation on CpG
islands of the imprinted gene SNRPN. In passage 7, the
methylation rate is 32e47% in six single-cell clones of
amniotic fluid stem cell (Table 2). Further studies on different
passages (passages 8e10) of six single-cell clones of amniotic
fluid stem cells shows there were variable methylation pattern
changes during in vitro cell culture with methylation rates of
21e88% (Table 2).
Epigenetic characteristics of CpG islands of imprinted
gene KCNQ1OT1 in six single-cell clones derived from
human AFMSCs and the effect of in vitro cell culture onchymal stem cells. Each single-cell clone of amniotic fluid mesenchymal stem
e characterized. Flow cytometry analyses revealed the expression of stem cell
amniotic fluid MSCs.
Fig. 3. Induction potential of single-cell clones of amniotic fluid mesenchymal stem cells. To demonstrate osteogenic differentiation in each single-cell clone of
amniotic fluid MSCs, the mineralization of calcium accumulation in the cells was made visible by von Kossa staining. All six clones of amniotic fluid MSCs
showed aggregates of calcium mineralization within the cells, and five of them have strongly positive signals.
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AFMSCs.
In the six single-cell clones of human AFMSCs, the DNA
methylation patterns all showed a unique epigenetic signature
of hypermethylation in the CpG island of the imprinted gene
KCNQ1OT1 with only one exception. In passage 7, the
methylation rates ranged from 96% to 99% in five single-cell
clones of AFMSCs; only one clone had a significantly lower
methylation rate of 39% (Table 3). Further studies on different
passages (passages 8e10) show that there were no significant
methylation pattern changes during in vitro cell culture. We
found that during in vitro cell culture in passages 8e10 of sixTable 1
Methylation pattern on imprinting center of H19.
H19 C (%) B (%)
H19-C1P7 93 7
H19-C1P8 90 10
H19-C1P9 90 10
H19-C1P10 96 4
H19-C2P7 98 2
H19-C2P8 50 50
H19-C2P9 83 17
H19-C2P10 81 19
H19-C3P7 79 21
H19-C3P8 69 31
H19-C3P9 39 61
H19-C3P10 79 21
H19-C4P7 94 6
H19-C4P8 94 6
H19-C4P9 93 7
H19-C4P10 96 4
H19-C5P7 79 21
H19-C5P8 93 7
H19-C5P9 69 31
H19-C5P10 65 35
H19-C6P7 92 8
H19-C6P8 70 30
H19-C6P9 69 31
H19-C6P10 78 22
C ¼ methylated; B ¼ unmethylated; C ¼ clone; P ¼ passage.single-cell clones of amniotic fluid stem cells, all of them were
hypermethylated with methylation rates of 71e99% (Table 3).
Discussion
Stem cells can be derived from a variety of tissues during
embryo, fetal, and adult development [29e32]. Recently,
several studies have shown the possibility of deriving
progenitors from amniotic fluid [1e4]. Amniotic fluid is the
liquid surrounding the fetus, and the main component of
amniotic fluid is fetal urine. The fetal cells from urinary tract,
gastrointestinal tract, respiratory tract, skin, and other organsTable 2
Methylation pattern on imprinting center of SNRPN.
SNRPN C (%) B (%)
SNRPN-C1P7 32 68
SNRPN-C1P8 80 20
SNRPN-C1P9 66 34
SNRPN-C1P10 77 23
SNRPN-C2P7 36 64
SNRPN-C2P8 37 63
SNRPN-C2P9 21 79
SNRPN-C2P10 26 74
SNRPN-C3P7 34 66
SNRPN-C3P8 50 50
SNRPN-C3P9 88 12
SNRPN-C3P10 46 54
SNRPN-C4P7 46 54
SNRPN-C4P8 78 22
SNRPN-C4P9 33 67
SNRPN-C4P10 96 4
SNRPN-C5P7 47 53
SNRPN-C5P8 65 35
SNRPN-C5P9 82 18
SNRPN-C5P10 49 51
SNRPN-C6P7 32 68
SNRPN-C6P8 45 55
SNRPN-C6P9 52 48
SNRPN-C6P10 41 59
C ¼ methylated;B ¼ unmethylated; C ¼ clone; P ¼ passage.
Table 3
Methylation pattern on imprinting center of KCNQ1OT1.
KCNQ1OT1 C (%) B (%)
KCNQ1OT1-C1P7 39 61
KCNQ1OT1-C1P8 95 5
KCNQ1OT1-C1P9 96 4
KCNQ1OT1-C1P10 80 20
KCNQ1OT1-C2P7 96 4
KCNQ1OT1-C2P8 96 4
KCNQ1OT1-C2P9 97 3
KCNQ1OT1-C2P10 77 23
KCNQ1OT1-C3P7 97 3
KCNQ1OT1-C3P8 81 19
KCNQ1OT1-C3P9 97 3
KCNQ1OT1-C3P10 97 3
KCNQ1OT1-C4P7 98 2
KCNQ1OT1-C4P8 83 17
KCNQ1OT1-C4P9 81 19
KCNQ1OT1-C4P10 99 1
KCNQ1OT1-C5P7 99 1
KCNQ1OT1-C5P8 80 20
KCNQ1OT1-C5P9 75 25
KCNQ1OT1-C5P10 79 21
KCNQ1OT1-C6P7 97 3
KCNQ1OT1-C6P8 71 29
KCNQ1OT1-C6P9 82 18
KCNQ1OT1-C6P10 83 17
C ¼ methylated; B ¼ unmethylated; C ¼ clone; P ¼ passage.
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a widely accepted method of prenatal diagnosis, and the extra
samples can be used to isolate AFMSCs, which has raised
fewer ethical issues than other fetal stem cell sources, while
still representing a good candidate for cell therapeutic appli-
cations and tissue engineering [1]. The potential use of
AFMSCs for tissue regeneration were shown to be successful
in animal models, including cartilage [35], smooth muscle
[36], and cardiomyocyte cell sheet formation [37].
DNA methylation, which is responsible for gene silencing,
is an epigenetic system that determines the specific charac-
teristics of many cells, including stem cells. Until now, most
studies have focused on the epigenetic changes on embryonic
stem cells; however, the studies on DNA methylation patterns
of human AFMSCs are limited. It had been reported that the
DNA methylation patterns of hESCs are distinct from those in
other cells, which may further our understanding of the
mechanism behind stem cells’ pluripotency [26]. Another
report proposes gene-specific differences in the stability of
imprinted loci in hESCs and disrupted DNA methylation as
one potential mechanism [38]. Moreover, in vitro hESCs
differentiation causes epigenetic abnormalities such as
hypermethylation of CpG islands [27]. Recent studies suggest
that genetic lesions and epigenetic instability including
abnormal DNA methylation in cancer-related genes occur
during long-term passage of hESCs [39]. The more passages
the embryonic stem cells experienced, the more they appeared
to differ from other cells of the same line that underwent fewer
passages. This issue is important because alterations in DNA
methylation have been associated with cancer and human
genetic disorders [40]. Also, it is believed that the genome/epigenome damage may elevate the risk for adverse health
outcomes during various stages of life, contributing to prob-
lems with fertility and fetal development [41]. Because in vitro
cell culture may change the epigenetic characteristics of the
hESCs, it makes therapeutic cloning more challenging because
of concerns that these epigenetic changes could affect human
health, which can limit our applications of these in vitro cell
culture cells in human therapies, cell transplantation, and
tissue repair.
To our knowledge, this is the first study on the DNA
methylation patterns on DMRs of imprinting genes (H19,
SNRPN, and KCNQ1OT1) in human single-cell clones of
AFMSCs during in vitro cell culture. In our study, we found
that there is a hypermethylation pattern in the imprinting
center of H19, and there are no significant changes in meth-
ylation patterns in most passages of AFMSCs during in vitro
cell culture. In a previous report, abnormal hypermethylation
within the IGF2/H19 imprinting center was found in monkey
ESC lines [42]. In mouse multipotent germ line stem cells, the
imprinting center of H19 is hypermethylated during in vitro
cell culture [43]. In a review article on human ESC cells,
variable epigenetic stability is observed [44]. In our study,
there is variable methylation pattern on the imprinting center
of SNRPN in single-cell clones of AFMSCs, and there are also
variable changes in methylation patterns during in vitro cell
culture. In a previous report, the SNURF/SNRPN imprinting
centers are differentially methylated in monkey ESC lines
[42]. Another report on methylation patterns of the Snurf/
Snrpn cluster in mouse ES cells exhibited notable stability
during in vitro manipulation [45]. In human ESCs, SNRPN is
highly epigenetically stable [44]. In our study, there are altered
methylation patterns (hypermethylation) at the imprinting
center of KCNQ1OT1 in single-cell clones of AFMSCs, and
there are no significant changes in methylation patterns in all
passages during in vitro cell culture. In a previous report,
KCNQ1OT1 is highly epigenetically stable in human ESCs
[44]. Based on these findings, we know that DNA methylation
patterns at the imprinting center of imprinting genes might be
quite different in different source of stem cells and species.
Our study on the epigenetics of AFMSCs is an interesting
initial look into what might be done for these stem cells that
can potentially be applicable in therapies and tissue engi-
neering. From the results of our study, we know about the
altered DNA methylation pattern (hypermethylation) of H19
and KCNQ1OT1 of human single-cell clones of AFMSCs,
which might cause therapeutic cloning to face enormous
challenges. On the other hand, we found the variable epige-
netic status of SNRPN in human AFMSCs during in vitro cell
culture. These findings may have an impact on the suitability
of AFMSCs for therapeutic use. Therefore, periodic moni-
toring of these cell lines may be required before they are used
in in vivo applications.
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